Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)

Market Cap	143.39B
Revenue (ttm)	19.76B +23.5%
Net Income	1.26B +40.6%
EPS	3.96 +28.5%
Shares Out	316.81M
PE Ratio	114.17
Forward PE	85.57
Dividend	n/a
Ex-Dividend Date	n/a

Volume	64,194
Average Volume	135,415
Open	451.25
Previous Close	453.00
Day's Range	444.15 - 454.75
52-Week Range	327.00 - 568.00
Beta	n/a
RSI	42.67
Earnings Date	Feb 3, 2026

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the tr...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AGARWALEYE

Financial Performance

In fiscal year 2025, Dr. Agarwal's Health Care's revenue was 17.11 billion, an increase of 28.44% compared to the previous year's 13.32 billion. Earnings were 834.60 million, an increase of 0.48%.